Gilead Sciences (GILD) EV to EBITDA (2009 - 2026)
Gilead Sciences' EV to EBITDA came in at 583.75 for Q2 2026, compared with 12.24 a year earlier.
Powered by 
Analysis
Gilead Sciences (GILD) EV to EBITDA (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Gilead Sciences reported EV to EBITDA of 497.72; for FY2025, it came in at 11.31, down 52.3% from FY2024.
- Going back by year, EV to EBITDA was 23.71 in FY2024 (+160.9%), 9.09 in FY2023 (-14.8%), 10.67 in FY2022 (+51.1%) and 7.06 in FY2021 (-40.3%).
- The Q2 2026 figure represents the highest quarterly EV to EBITDA in data going back to Q2 2009.
- Year-over-year, EV to EBITDA increased in three of the last seven quarters, with growth averaging 33.4%.
- The fastest year-over-year change in EV to EBITDA over five years came in Q3 2024 (growth of 245.8%), and the weakest in Q3 2025 (a decline of 64.5%).
- Business Quant data shows GILD's EV to EBITDA at 12.60 (Q1 2026), 11.31 (Q4 2025) and 9.84 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 130.49 Bn | 81.76 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 583.75 |
| Mar 31, 2026 | 12.60 |
| Dec 31, 2025 | 11.31 |
| Sep 30, 2025 | 9.84 |
| Jun 30, 2025 | 12.24 |
| Mar 31, 2025 | 11.96 |
| Dec 31, 2024 | 23.71 |
| Sep 30, 2024 | 27.72 |
| Jun 30, 2024 | 15.55 |
| Mar 31, 2024 | 20.01 |
| Dec 31, 2023 | 9.09 |
| Sep 30, 2023 | 8.02 |
| Jun 30, 2023 | 8.24 |
| Mar 31, 2023 | 8.83 |
| Dec 31, 2022 | 10.67 |
| Sep 30, 2022 | 8.83 |
| Jun 30, 2022 | 7.88 |
| Mar 31, 2022 | 7.43 |
| Dec 31, 2021 | 7.06 |
| Sep 30, 2021 | 6.04 |
API Access
Gilead Sciences EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();